87 GMP injectable manufacturers violated facility standard rules

The Korea Food and Drug Administration announced it discovered 87 GMP-accredited injectable manufacturers that violated the facility standard rules as a result of its special six-month inspection of 111 manufacturers from February to July this year.

According to KPDA officials, this inspection was promoted by the sudden death of an individual receiving an injectable preparation in October 2...